A research study of an ayurvedic drug Shadpallava churna in women aged 21-40 years for a period of 10 days in the condition of white discharge per vagina.

An open label double arm randomised controlled clinical study of Shadpallava churna in Shweta pradara. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085718

Enrollment

Registered

2025-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married women at the age group of 21-40 years. 2. Patient diagnosed with shweta pradara.

Exclusion criteria

Exclusion criteria: 1.Pregnant women 2.Puerperal women 3.Patient with STD 4.Patient with systemic illness (like uncontrolled DM, HTN) 5.Patient on contraceptive pills 6.Patient with Intra uterine contraceptive device 7.Patient with cervical polyp 8.Patient with cervical erosion

Design outcomes

Primary

Measure	Time frame
Significant reduction in signs and symptoms of Shweta pradara based on grading.Timepoint: Baseline, 10 days	—

Secondary

Measure	Time frame
Significant effect of shadpallava churna in improving the quality of life in the patients diagnosed with shweta pradara.Timepoint: Baseline, 10 days	—

Countries

India

Contacts

Public ContactDr Pramodini J Patil

Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Bangalore

dr.pramodinip@gmail.com8496841492

Outcome results